![AET AET](https://data.pdbj.org/pdbjplus/data/cc/svg/AET.svg) | AET | Name: | N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL)METHYLCARBAMOYL]THREONINE-5'-MONOPHOSPHATE | Formula: | C16 H23 N6 O11 P | SMILES: | O=C(O)C(NC(=O)N(c3ncnc1c3ncn1C2OC(C(O)C2O)COP(=O)(O)O)C)C(O)C | InChi: | InChI=1S/C16H23N6O11P/c1-6(23)8(15(26)27)20-16(28)21(2)12-9-13(18-4-17-12)22(5-19-9)14-11(25)10(24)7(33-14)3-32-34(29,30)31/h4-8,10-11,14,23-25H,3H2,1-2H3,(H,20,28)(H,26,27)(H2,29,30,31)/t6-,7-,8+,10-,11-,14-/m1/s1 | Synonyms: | N-(NEBULARIN-6-YL-METHYLCARBAMOYL)-L-THREONINE-5'-MONOPHOSPHATE | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | (2S,3R)-2-{[(9-{(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-9H-purin-6-yl)(methyl)carbamoyl]amino}-3-hydroxybutanoic acid (non-preferred name) |
|
![MUS MUS](https://data.pdbj.org/pdbjplus/data/cc/svg/MUS.svg) | MUS | Name: | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID | Formula: | C21 H25 N O11 | SMILES: | O=C3Oc2c(ccc(OC1(OC(C(O)C(O)CO)C(NC(=O)C)C(O)C1)C(=O)O)c2)C(=C3)C | InChi: | InChI=1S/C21H25NO11/c1-9-5-16(27)31-15-6-11(3-4-12(9)15)32-21(20(29)30)7-13(25)17(22-10(2)24)19(33-21)18(28)14(26)8-23/h3-6,13-14,17-19,23,25-26,28H,7-8H2,1-2H3,(H,22,24)(H,29,30)/t13-,14+,17+,18+,19+,21+/m0/s1 | Synonyms: | METHYLUMBELLIFERYL SIALIC ACID | Definition date: | 2004-01-19 | Last modified: | 2021-03-01 | Identifier: | 4-methyl-2-oxo-2H-chromen-7-yl 5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid |
|
![AF0 AF0](https://data.pdbj.org/pdbjplus/data/cc/svg/AF0.svg) | AF0 | Name: | N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)methanesulfonamide | Formula: | C20 H20 F4 N2 O3 S | SMILES: | c1(c(c(c(c(c1F)F)C)F)F)CS(Nc3cc2CCC(N(CCC)c2cc3)=O)(=O)=O | InChi: | InChI=1S/C20H20F4N2O3S/c1-3-8-26-15-6-5-13(9-12(15)4-7-16(26)27)25-30(28,29)10-14-19(23)17(21)11(2)18(22)20(14)24/h5-6,9,25H,3-4,7-8,10H2,1-2H3 | Synonyms: | AMF4 | Definition date: | 2017-05-15 | Last modified: | 2021-03-01 | Release date: | 2017-11-15 | Identifier: | N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(2,3,5,6-tetrafluoro-4-methylphenyl)methanesulfonamide |
|
![006 006](https://data.pdbj.org/pdbjplus/data/cc/svg/006.svg) | 006 | Name: | (4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}-2-hydroxy-4-phenylbutanoyl]-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide | Formula: | C35 H41 N3 O6 S | SMILES: | O=C(NC2c1ccccc1CC2O)C5N(C(=O)C(O)C(NC(=O)COc3c(cccc3C)C)Cc4ccccc4)CSC5(C)C | InChi: | InChI=1S/C35H41N3O6S/c1-21-11-10-12-22(2)31(21)44-19-28(40)36-26(17-23-13-6-5-7-14-23)30(41)34(43)38-20-45-35(3,4)32(38)33(42)37-29-25-16-9-8-15-24(25)18-27(29)39/h5-16,26-27,29-30,32,39,41H,17-20H2,1-4H3,(H,36,40)(H,37,42)/t26-,27+,29-,30-,32+/m0/s1 | Synonyms: | KNI-10006 | Definition date: | 2008-07-03 | Last modified: | 2021-03-01 | Identifier: | (4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]amino}-2-hydroxy-4-phenylbutanoyl]-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide |
|
![MVC MVC](https://data.pdbj.org/pdbjplus/data/cc/svg/MVC.svg) | MVC | Name: | MONOVACCENIN | Formula: | C21 H40 O4 | SMILES: | O=C(OCC(O)CO)CCCCCCCCCC=C/CCCCCC | InChi: | InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h7-8,20,22-23H,2-6,9-19H2,1H3/b8-7-/t20-/m1/s1 | Synonyms: | 11.7 MAG | Definition date: | 2011-06-08 | Last modified: | 2021-03-01 | Identifier: | (2R)-2,3-dihydroxypropyl (11Z)-octadec-11-enoate |
|
![00K 00K](https://data.pdbj.org/pdbjplus/data/cc/svg/00K.svg) | 00K | Name: | (1S,7S)-7-amino-N-[(2R,3S)-7-amino-1-(cyclohexylamino)-2-hydroxy-1-oxoheptan-3-yl]-7-benzyl-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C28 H44 N6 O4 | SMILES: | O=C(NC1CCCCC1)C(O)C(NC(=O)C3N2C(=O)C(N)(CCN2CC3)Cc4ccccc4)CCCCN | InChi: | InChI=1S/C28H44N6O4/c29-16-8-7-13-22(24(35)26(37)31-21-11-5-2-6-12-21)32-25(36)23-14-17-33-18-15-28(30,27(38)34(23)33)19-20-9-3-1-4-10-20/h1,3-4,9-10,21-24,35H,2,5-8,11-19,29-30H2,(H,31,37)(H,32,36)/t22-,23-,24-,28+/m0/s1 | Synonyms: | MOL-106 | Definition date: | 2010-10-27 | Last modified: | 2021-03-01 | Identifier: | (1S,7S)-7-amino-N-[(2S,3S)-7-amino-1-(cyclohexylamino)-2-hydroxy-1-oxoheptan-3-yl]-7-benzyl-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide |
|
![00L 00L](https://data.pdbj.org/pdbjplus/data/cc/svg/00L.svg) | 00L | Name: | (1S,7S)-7-amino-7-benzyl-N-[(1S)-4-carbamimidamido-1-{(1S)-1-hydroxy-2-oxo-2-[(2-phenylethyl)amino]ethyl}butyl]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C30 H42 N8 O4 | SMILES: | O=C(NCCc1ccccc1)C(O)C(NC(=O)C3N2C(=O)C(N)(CCN2CC3)Cc4ccccc4)CCCNC(=[N@H])N | InChi: | InChI=1S/C30H42N8O4/c31-29(32)35-16-7-12-23(25(39)27(41)34-17-13-21-8-3-1-4-9-21)36-26(40)24-14-18-37-19-15-30(33,28(42)38(24)37)20-22-10-5-2-6-11-22/h1-6,8-11,23-25,39H,7,12-20,33H2,(H,34,41)(H,36,40)(H4,31,32,35)/t23-,24-,25-,30+/m0/s1 | Synonyms: | MOL-126 | Definition date: | 2010-10-28 | Last modified: | 2021-03-01 | Identifier: | (1S,7S)-7-amino-7-benzyl-N-{(2S,3S)-6-carbamimidamido-2-hydroxy-1-oxo-1-[(2-phenylethyl)amino]hexan-3-yl}-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide |
|
![MWB MWB](https://data.pdbj.org/pdbjplus/data/cc/svg/MWB.svg) | MWB | Name: | N1-(4,5-dihydro-1H-imidazol-2-yl)-N4-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)phenyl)benzene-1,4-diamine | Formula: | C18 H21 N7 | SMILES: | N4=C(Nc3ccc(Nc2ccc(NC1=NCCN1)cc2)cc3)NCC4 | InChi: | InChI=1S/C18H21N7/c1-5-15(24-17-19-9-10-20-17)6-2-13(1)23-14-3-7-16(8-4-14)25-18-21-11-12-22-18/h1-8,23H,9-12H2,(H2,19,20,24)(H2,21,22,25) | Synonyms: | CD27 | Definition date: | 2014-02-04 | Last modified: | 2021-03-01 | Release date: | 2014-06-11 | Identifier: | N-(4,5-dihydro-1H-imidazol-2-yl)-N'-[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine |
|
![01K 01K](https://data.pdbj.org/pdbjplus/data/cc/svg/01K.svg) | 01K | Name: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl (3R,20R)-20-carbamoyl-3-hydroxy-2,2-dimethyl-4,8,14,22-tetraoxo-12-thia-5,9,15,21-tetraazatricos-1-yl dihydrogen diphosphate | Formula: | C31 H53 N10 O19 P3 S | SMILES: | O=C(N)C(NC(=O)C)CCCCNC(=O)CSCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3OP(=O)(O)O | InChi: | InChI=1S/C31H53N10O19P3S/c1-17(42)40-18(27(33)47)6-4-5-8-34-21(44)13-64-11-10-35-20(43)7-9-36-29(48)25(46)31(2,3)14-57-63(54,55)60-62(52,53)56-12-19-24(59-61(49,50)51)23(45)30(58-19)41-16-39-22-26(32)37-15-38-28(22)41/h15-16,18-19,23-25,30,45-46H,4-14H2,1-3H3,(H2,33,47)(H,34,44)(H,35,43)(H,36,48)(H,40,42)(H,52,53)(H,54,55)(H2,32,37,38)(H2,49,50,51)/t18-,19-,23-,24-,25+,30-/m1/s1 | Synonyms: | Lysine-COENZYME A derivative | Definition date: | 2007-12-13 | Last modified: | 2021-03-01 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl (3R,20R)-20-carbamoyl-3-hydroxy-2,2-dimethyl-4,8,14,22-tetraoxo-12-thia-5,9,15,21-tetraazatricos-1-yl dihydrogen diphosphate |
|
![MX7 MX7](https://data.pdbj.org/pdbjplus/data/cc/svg/MX7.svg) | MX7 | Name: | (2R)-3-(phosphonooxy)propane-1,2-diyl (9Z,9'Z)bis-octadec-9-enoate | Formula: | C39 H73 O8 P | SMILES: | O=C(OC(COP(=O)(O)O)COC(=O)CCCCCCCC=C/CCCCCCCC)CCCCCCCC=C/CCCCCCCC | InChi: | InChI=1S/C39H73O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,37H,3-16,21-36H2,1-2H3,(H2,42,43,44)/b19-17-,20-18-/t37-/m1/s1 | Synonyms: | dioleoyl-phosphatidic acid | Definition date: | 2013-09-30 | Last modified: | 2021-03-01 | Release date: | 2014-10-01 | Identifier: | (2R)-3-(phosphonooxy)propane-1,2-diyl (9Z,9'Z)bis-octadec-9-enoate |
|
![02L 02L](https://data.pdbj.org/pdbjplus/data/cc/svg/02L.svg) | 02L | Name: | N-(2,2-dimethylpropyl)-L-asparagine | Formula: | C9 H18 N2 O3 | SMILES: | O=C(NCC(C)(C)C)CC(N)C(=O)O | InChi: | InChI=1S/C9H18N2O3/c1-9(2,3)5-11-7(12)4-6(10)8(13)14/h6H,4-5,10H2,1-3H3,(H,11,12)(H,13,14)/t6-/m0/s1 | Synonyms: | N-beta-neopentyl asparagine | Definition date: | 2011-06-17 | Last modified: | 2021-03-01 | Identifier: | N-(2,2-dimethylpropyl)-L-asparagine |
|
![MXL MXL](https://data.pdbj.org/pdbjplus/data/cc/svg/MXL.svg) | MXL | Name: | MOXALACTAM | Formula: | C20 H20 N6 O9 S | SMILES: | O=C2N1C(=C(COC1C2(OC)NC(=O)C(c3ccc(O)cc3)C(=O)O)CSc4nnnn4C)C(=O)O | InChi: | InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12-,18-,20+/m1/s1 | Synonyms: | 7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-(3-((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-OXA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID | Definition date: | 2001-10-30 | Last modified: | 2021-03-01 | Identifier: | (6R,7R)-7-{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
![MXR MXR](https://data.pdbj.org/pdbjplus/data/cc/svg/MXR.svg) | MXR | Name: | (2S,3R,4S)-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | Formula: | C17 H27 N3 O5 S | SMILES: | O=C(O)C2=NC(C(C2SC1CC(C(=O)N(C)C)NC1)C)C(C=O)C(O)C | InChi: | InChI=1S/C17H27N3O5S/c1-8-13(11(7-21)9(2)22)19-14(17(24)25)15(8)26-10-5-12(18-6-10)16(23)20(3)4/h7-13,15,18,22H,5-6H2,1-4H3,(H,24,25)/t8-,9-,10+,11-,12-,13-,15+/m1/s1 | Synonyms: | meropenem bound form (tautomerism) | Definition date: | 2012-10-02 | Last modified: | 2021-03-01 | Release date: | 2013-06-19 | Identifier: | (2S,3R,4S)-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
![039 039](https://data.pdbj.org/pdbjplus/data/cc/svg/039.svg) | 039 | Name: | 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE | Formula: | C21 H15 Cl N6 O2 S | SMILES: | Clc2cccc3N=C(N(c1ccccc1OC)C(=O)c23)CSc5ncnc4c5ncn4 | InChi: | InChI=1S/C21H15ClN6O2S/c1-30-15-8-3-2-7-14(15)28-16(27-13-6-4-5-12(22)17(13)21(28)29)9-31-20-18-19(24-10-23-18)25-11-26-20/h2-8,10-11H,9H2,1H3,(H,23,24,25,26) | Synonyms: | PIK-39 | Definition date: | 2006-03-16 | Last modified: | 2021-03-01 | Identifier: | 5-chloro-3-(2-methoxyphenyl)-2-[(9H-purin-6-ylsulfanyl)methyl]quinazolin-4(3H)-one |
|
![03G 03G](https://data.pdbj.org/pdbjplus/data/cc/svg/03G.svg) | 03G | Name: | N-(4-chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)ethanediamide | Formula: | C17 H24 Cl N3 O2 | SMILES: | Clc1ccc(cc1)NC(=O)C(=O)NC2CC(NC(C)(C)C2)(C)C | InChi: | InChI=1S/C17H24ClN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23) | Synonyms: | NBD-556 | Definition date: | 2011-08-24 | Last modified: | 2021-03-01 | Identifier: | N-(4-chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)ethanediamide |
|
![03H 03H](https://data.pdbj.org/pdbjplus/data/cc/svg/03H.svg) | 03H | Name: | (2S)-2-chloro-4-methylpentanoic acid | Formula: | C6 H11 Cl O2 | SMILES: | ClC(C(=O)O)CC(C)C | InChi: | InChI=1S/C6H11ClO2/c1-4(2)3-5(7)6(8)9/h4-5H,3H2,1-2H3,(H,8,9)/t5-/m0/s1 | Synonyms: | (S)-alpha-chloroisocaproate | Definition date: | 2011-09-28 | Last modified: | 2021-03-01 | Release date: | 2012-09-28 | Identifier: | (2S)-2-chloro-4-methylpentanoic acid |
|
![MYK MYK](https://data.pdbj.org/pdbjplus/data/cc/svg/MYK.svg) | MYK | Name: | N~6~-tetradecanoyl-L-lysine | Formula: | C20 H40 N2 O3 | SMILES: | O=C(O)C(N)CCCCNC(=O)CCCCCCCCCCCCC | InChi: | InChI=1S/C20H40N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-16-19(23)22-17-14-13-15-18(21)20(24)25/h18H,2-17,21H2,1H3,(H,22,23)(H,24,25)/t18-/m0/s1 | Synonyms: | N6-myristoyl lysine | Definition date: | 2011-10-17 | Last modified: | 2021-03-01 | Identifier: | N~6~-tetradecanoyl-L-lysine |
|
![03P 03P](https://data.pdbj.org/pdbjplus/data/cc/svg/03P.svg) | 03P | Name: | N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide | Formula: | C26 H25 Cl F3 N5 O3 | SMILES: | FC(F)(F)c4cc(Oc1ccc(cc1Cl)Nc2ncnc3c2n(cc3)CCNC(=O)CC(O)(C)C)ccc4 | InChi: | InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34) | Synonyms: | TAK-285 | Definition date: | 2010-11-30 | Last modified: | 2021-03-01 | Identifier: | N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide |
|
![MYQ MYQ](https://data.pdbj.org/pdbjplus/data/cc/svg/MYQ.svg) | MYQ | Name: | (S)-(1,2-DICARBOXYETHYLTHIO)GOLD | Formula: | C4 H5 Au O4 S | SMILES: | O=C(O)CC(S[Au])C(=O)O | InChi: | InChI=1S/C4H6O4S.Au/c5-3(6)1-2(9)4(7)8 | Synonyms: | MYOCRISIN | Definition date: | 2005-09-07 | Last modified: | 2021-03-01 | Identifier: | gold(1+) (1S)-1,2-dicarboxyethanethiolate |
|
![MYZ MYZ](https://data.pdbj.org/pdbjplus/data/cc/svg/MYZ.svg) | MYZ | Name: | Myristoleic acid | Formula: | C14 H26 O2 | SMILES: | O=C(O)CCCCCCCC=C/CCCC | InChi: | InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5- | Synonyms: | Z-tetradec-9-enoic acid | Definition date: | 2014-09-05 | Last modified: | 2021-03-01 | Release date: | 2015-02-25 | Identifier: | (9Z)-tetradec-9-enoic acid |
|
![MZB MZB](https://data.pdbj.org/pdbjplus/data/cc/svg/MZB.svg) | MZB | Name: | (1R,2R,3R,4S,5R)-4-amino-5-[(R)-methylsulfinyl]cyclopentane-1,2,3-triol | Formula: | C6 H13 N O4 S | SMILES: | O=S(C1C(O)C(O)C(O)C1N)C | InChi: | InChI=1S/C6H13NO4S/c1-12(11)6-2(7)3(8)4(9)5(6)10/h2-6,8-10H,7H2,1H3/t2-,3+,4+,5+,6+,12+/m0/s1 | Synonyms: | MANNOSTATIN B | Definition date: | 2008-07-25 | Last modified: | 2021-03-01 | Identifier: | (1R,2R,3R,4S,5R)-4-amino-5-[(R)-methylsulfinyl]cyclopentane-1,2,3-triol |
|
![04G 04G](https://data.pdbj.org/pdbjplus/data/cc/svg/04G.svg) | 04G | Name: | 7-hydroxy-3H-phenoxazin-3-one | Formula: | C12 H7 N O3 | SMILES: | O=C2C=CC1=Nc3c(OC1=C2)cc(O)cc3 | InChi: | InChI=1S/C12H7NO3/c14-7-1-3-9-11(5-7)16-12-6-8(15)2-4-10(12)13-9/h1-6,14H | Synonyms: | RESORUFIN | Definition date: | 2011-10-19 | Last modified: | 2021-03-01 | Identifier: | 7-hydroxy-3H-phenoxazin-3-one |
|
![04M 04M](https://data.pdbj.org/pdbjplus/data/cc/svg/04M.svg) | 04M | Name: | 5-(morpholin-4-ylsulfonyl)-2-{[3-(octyloxy)benzyl]oxy}benzoic acid | Formula: | C26 H35 N O7 S | SMILES: | O=S(=O)(N1CCOCC1)c3cc(C(=O)O)c(OCc2cccc(OCCCCCCCC)c2)cc3 | InChi: | InChI=1S/C26H35NO7S/c1-2-3-4-5-6-7-15-33-22-10-8-9-21(18-22)20-34-25-12-11-23(19-24(25)26(28)29)35(30,31)27-13-16-32-17-14-27/h8-12,18-19H,2-7,13-17,20H2,1H3,(H,28,29) | Synonyms: | BPH-1158 | Definition date: | 2011-06-16 | Last modified: | 2021-03-01 | Release date: | 2016-09-07 | Identifier: | 5-(morpholin-4-ylsulfonyl)-2-{[3-(octyloxy)benzyl]oxy}benzoic acid |
|
![MZM MZM](https://data.pdbj.org/pdbjplus/data/cc/svg/MZM.svg) | MZM | Name: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide | Formula: | C5 H8 N4 O3 S2 | SMILES: | NS(=O)(=O)C=1S/C(N(N=1)C)=NC(=O)C | InChi: | InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4- | Synonyms: | Methazolamide | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide |
|
![04W 04W](https://data.pdbj.org/pdbjplus/data/cc/svg/04W.svg) | 04W | Name: | 2-{[3-(decyloxy)benzyl]oxy}-5-nitrobenzoic acid | Formula: | C24 H31 N O6 | SMILES: | [O-][N+](=O)c2ccc(OCc1cccc(OCCCCCCCCCC)c1)c(c2)C(=O)O | InChi: | InChI=1S/C24H31NO6/c1-2-3-4-5-6-7-8-9-15-30-21-12-10-11-19(16-21)18-31-23-14-13-20(25(28)29)17-22(23)24(26)27/h10-14,16-17H,2-9,15,18H2,1H3,(H,26,27) | Synonyms: | BPH-1186 | Definition date: | 2011-06-17 | Last modified: | 2021-03-01 | Release date: | 2016-09-07 | Identifier: | 2-{[3-(decyloxy)benzyl]oxy}-5-nitrobenzoic acid |
|